synthet
combin
sidechain
structur
featur
antivir
candid
methylaristeromycin
homoaristeromycin
diastereomer
pair
sidechain
dihydroxyl
aristeromycin
report
broad
antivir
analys
target
found
promis
effect
toward
hbv
lm
lm
hcmv
lm
activ
found
neither
diastereom
cytotox
assay
perform
elsevi
ltd
right
reserv
report
biolog
inact
carbocycl
thymidin
introduc
new
class
nucleosid
synthesi
racem
carbocycl
adenosin
aristeromycin
subsequ
isol
enantiom
streptomyc
citricolor
era
carbocycl
nucleosid
began
becam
focal
point
pursuit
carbocycl
nucleosid
therapeut
candid
probe
biolog
process
interest
aristeromycin
analog
therefrom
began
report
noraristeromycin
activ
toward
human
cytomegaloviru
year
sinc
look
back
see
analog
lie
wake
work
suggest
look
structur
possibl
recent
regard
drawn
report
methylaristeromycin
homoaristeromycin
meaning
antivir
properti
develop
analog
design
stimul
us
consid
combin
two
side
chain
featur
diastereom
whose
design
deriv
homoaristeromycin
blue
possess
hydroxyl
outcom
pursuit
present
see
fig
oxid
alken
glycol
well
establish
synthet
organ
toolbox
thu
investig
known
protect
carbocycl
adenin
nucleosid
unsatur
side
chain
avail
dribos
serv
start
point
achiev
requisit
diastereom
admixa
admixb
employ
respect
deprotect
n
hydrochlor
acid
produc
synthet
combin
sidechain
structur
featur
antivir
candid
methylaristeromycin
homoaristeromycin
diastereomer
pair
sidechain
dihydroxyl
aristeromycin
report
broad
antivir
analys
target
found
promis
effect
toward
hbv
lm
lm
hcmv
lm
activ
found
neither
diastereom
cytotox
assay
perform
elsevi
ltd
right
reserv
report
biolog
inact
carbocycl
thymidin
introduc
new
class
nucleosid
synthesi
racem
carbocycl
adenosin
aristeromycin
subsequ
isol
enantiom
streptomyc
citricolor
era
carbocycl
nucleosid
began
becam
focal
point
pursuit
carbocycl
nucleosid
therapeut
candid
probe
biolog
process
interest
aristeromycin
analog
therefrom
began
report
noraristeromycin
activ
toward
human
cytomegaloviru
year
sinc
look
back
see
analog
lie
wake
work
suggest
look
structur
possibl
recent
regard
drawn
report
methylaristeromycin
homoaristeromycin
meaning
antivir
properti
develop
analog
design
stimul
us
consid
combin
two
side
chain
featur
diastereom
whose
design
deriv
homoaristeromycin
blue
possess
hydroxyl
outcom
pursuit
present
see
fig
oxid
alken
glycol
well
establish
synthet
organ
toolbox
thu
investig
known
protect
carbocycl
adenin
nucleosid
unsatur
side
chain
avail
dribos
serv
start
point
achiev
requisit
diastereom
admixa
admixb
employ
respect
deprotect
n
hydrochlor
acid
produc
stereochemistri
determin
mesyl
deprotect
reduct
remov
mesyl
lithium
aluminum
hydrid
yield
conveni
altern
synthesi
diastereom
spectroscop
properti
ident
previous
report
address
possibl
structur
ambigu
studi
confirm
achiev
xray
structur
analysi
antivir
analysi
show
moder
activ
toward
hepat
b
ec
lm
lm
respect
cc
lm
potent
human
cytomegaloviru
ec
lm
cc
lm
compound
found
lack
signific
yellow
fever
properti
report
indic
addit
hydroxyl
methyl
carbon
result
undesir
outcom
futur
develop
yellow
fever
antivir
candid
similar
conclus
reach
loss
orthopox
activ
due
presenc
extra
hydroxyl
group
posit
diastereom
see
scheme
antivir
analysi
show
moder
activ
toward
hepat
b
ec
lm
lm
respect
cc
lm
potent
human
cytomegaloviru
ec
lm
cc
lm
compound
found
lack
signific
yellow
fever
properti
report
indic
addit
hydroxyl
methyl
carbon
result
undesir
outcom
futur
develop
yellow
fever
antivir
candid
similar
conclus
reach
loss
orthopox
activ
due
presenc
extra
hydroxyl
group
posit
diastereom
compound
inact
toward
polio
viru
sar
coronaviru
respiratori
syncyti
viru
hepat
c
viru
herp
simplex
virus
vaccinia
viru
dengu
rift
valley
fever
venezuelan
equin
enceph
influenza
viru
west
nile
viru
cytotox
found
either
assay
conduct
conclus
conveni
synthesi
diastereomer
hybrid
methylaristeromycin
homoaristeromycin
homoaristeromycin
provid
new
structur
entiti
aristeromycin
famili
analog
show
potent
hbv
moder
hcmv
activ
note
hydroxyl
substitu
offer
opportun
make
substitu
chang
center
possibl
new
aristeromycin
structur
variat
